Boston Scientific Corporation (BSX) Should Continue Uptrend & Remain Supported
Boston Scientific Corporation (BSX) develops, manufactures & markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg & Cardiovascular segments. It offers devices to diagnose & treat different medical conditions and offer remote patient management systems. It is based in Marlborough, US, comes under Healthcare sector & trades as “BSX” ticker at NYSE.
As discussed in previous article, BSX reacted higher since $48.35 low & extend higher within the sequence started from October-2023 low. It erased the momentum divergence in daily suggesting further upside to continue as ((3)) of III in impulse sequence.
BSX - Elliott Wave Latest Daily View:
In weekly sequence, it placed (II) at $24.10 low in March-2020 & II of (III) at $34.98 low in June-2022. Above there, it favors upside in (1) of ((3)) of III & expect to remain supported in 3, 7 or 11 swings pullback. It placed ((1)) of I at $42.37 high, ((2)) at $32.99 low, ((3)) at $46.28 high, ((4)) at 37.96 low & ((5)) as I at $47.49 high. It placed ((1)) of III at $55.38 high & ((2)) at $48.35 low as shallow pullback. Within ((1)) of III, it placed (1) at $43.52 high, (2) at $37.74 low, (3) at $54.74 high, (4) at 49.69 low & finally (5) at $55.38 high as ((1)).
BSX - Elliott Wave Latest Weekly View:
Above ((2)) low, it favors upside in ((iii)) of 3 & expect further higher to finish (1) of ((3)). It placed 1 of (1) at $51.43 high & 2 at $49.15 low as flat correction. Above there, it favored ended ((ii)) at $54.95 low & favors upside in ((iii)) of 3 of (1). It expects few more highs to finish (1) of ((3)) before the next pullback may starts in (2) correction, which unfold in 3, 7 or 11 swings before resume upside in (3) of ((3)).
On the date of publication, Elliott Wave Forecast did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.